Anti-MYH6 + Slow Skeletal Myosin Heavy chain antibody [EPR10891(2)]
- BOND RX™ Validated
- 20ul selling size
- Recombinant
- Advanced Validation
- RabMAb
- What is this?
Be the first to review this product! Submit a review
|
(10 Publications)
Rabbit Recombinant Monoclonal MYH6 antibody. Suitable for mIHC, WB, IHC-P and reacts with Human, Mouse, Rat samples. Cited in 10 publications.
View Alternative Names
MYHCA, MYH6, Myosin-6, Myosin heavy chain 6, MyHC-alpha, MYHCB, MYH7, Myosin-7, Myosin heavy chain 7, Myosin heavy chain slow isoform, MyHC-slow, MyHC-beta
- IHC-P
Supplier Data
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-MYH6 + Slow Skeletal Myosin Heavy chain antibody [EPR10891(2)] (AB185967)
Immunohistochemical analysis of paraffin embedded Human skeletal muscle tissue labeling Slow Skeletal Myosin Heavy chain with ab185967 at 1/2000 dilution. Counterstained with Hematoxylin.
Perform heat mediated antigen retrieval with EDTA buffer pH 9 before commencing with IHC staining protocol.
- mIHC
Supplier Data
Multiplex immunohistochemistry - Anti-MYH6 + Slow Skeletal Myosin Heavy chain antibody [EPR10891(2)] (AB185967)
Fluorescence multiplex immunohistochemical analysis of the human skeletal muscle (Formalin/PFA-fixed paraffin-embedded sections). Panel A : merged staining of anti-delta Sarcoglycan (ab137101, red; Opal™690), anti-MYH2 (ab264036, cyan; Opal™520) and anti-MYH6 + Slow Skeletal Myosin Heavy chain (ab250868, gray; Opal™570) on human skeletal muscle. Panel B : anti-MYH2 stained on the fast twitch type 2A fibers. Panel C : anti-MYH6 + Slow Skeletal Myosin Heavy chain stained on skeletal muscle fiber subtypes. Panel D : anti-delta Sarcoglycan stained on membrane of skeletal muscle. Opal Polymer HRP Ms + Rb was used as a secondary antibody. The section was incubated in three rounds of staining : in the order of ab137101 at 1/1000 dilution (1.043 μg/ml), ab264036 at 1/1000 dilution (1.116 μg/ml) and ab250868 1/5000 dilution (0.209 μg/ml) for 30 mins at room temperature. Each round was followed by a separate fluorescent tyramide signal amplification system. DAPI (blue) was used as a nuclear counter stain. The immunostaining was performed on a Leica Biosystems BOND® RX instrument with an Opal™ 4-color kit. Image acquisition was performed with Leica SP8 confocal microscope. Heat mediated antigen retrieval with Tris-EDTA buffer (pH 9.0, epitope retrieval solution2) for 20 mins. This data was developed using the same antibody clone in a different buffer formulation (ab250868).
- WB
Lab
Western blot - Anti-MYH6 + Slow Skeletal Myosin Heavy chain antibody [EPR10891(2)] (AB185967)
This blot was produced using a 4-12% Bis-tris gel under the MOPS buffer system. The gel was run at 200V for 50 minutes before being transferred onto a Nitrocellulose membrane at 30V for 70 minutes. The membrane was then blocked for an hour using Licor blocking buffer before being incubated with ab185967 overnight at 4°C. Antibody binding was detected using Goat anti Rabbit IR680 at a 1 : 10,000 dilution for 1hr at room temperature and then imaged using the Licor Odyssey CLx.
All lanes:
Western blot - Anti-MYH6 + Slow Skeletal Myosin Heavy chain antibody [EPR10891(2)] (ab185967) at 1/500 dilution
Lane 1:
Human adult heart lysate at 20 µg
Lane 2:
Mouse heart lysate at 20 µg
Lane 3:
Rat heart lysate at 20 µg
Secondary
All lanes:
Goat anti Rabbit IR680 at 1/10000 dilution
Predicted band size: 36 kDa,41 kDa
false
- WB
Unknown
Western blot - Anti-MYH6 + Slow Skeletal Myosin Heavy chain antibody [EPR10891(2)] (AB185967)
ab185967 could recognize both Myosin 6 and 7 protein
All lanes:
Western blot - Anti-MYH6 + Slow Skeletal Myosin Heavy chain antibody [EPR10891(2)] (ab185967) at 1/1000 dilution
All lanes:
His tagged recombinant Human Myosin-6 protein(aa 1193-1337) at 0.01 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/20000 dilution
false
- WB
Unknown
Western blot - Anti-MYH6 + Slow Skeletal Myosin Heavy chain antibody [EPR10891(2)] (AB185967)
ab185967 could recognize both Myosin 6 and 7 protein
All lanes:
Western blot - Anti-MYH6 + Slow Skeletal Myosin Heavy chain antibody [EPR10891(2)] (ab185967) at 1/1000 dilution
All lanes:
His tagged recombinant Human Myosin-7 protein(aa 1191-1335) at 0.01 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/20000 dilution
false
Related conjugates and formulations (1)
-
Anti-MYH6 + Slow Skeletal Myosin Heavy chain antibody [EPR10891(2)] - BSA and Azide free
Reactivity data
Product details
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Publications (10)
Recent publications for all applications. Explore the full list and refine your search
Molecular biomedicine 5:31 PubMed39117956
2024
Applications
Unspecified application
Species
Unspecified reactive species
Journal of the American Heart Association 12:e027621 PubMed36927008
2023
Applications
Unspecified application
Species
Unspecified reactive species
Cellular & molecular biology letters 27:66 PubMed35945510
2022
Applications
Unspecified application
Species
Unspecified reactive species
Molecular medicine reports 24: PubMed34664684
2021
Applications
Unspecified application
Species
Unspecified reactive species
Frontiers in cell and developmental biology 9:692028 PubMed34395424
2021
Applications
Unspecified application
Species
Unspecified reactive species
Molecular medicine reports 20:4843-4854 PubMed31661144
2019
Applications
Unspecified application
Species
Unspecified reactive species
The Journal of endocrinology 242:199-210 PubMed31277074
2019
Applications
Unspecified application
Species
Unspecified reactive species
American journal of physiology. Heart and circulat 317:H405-H414 PubMed31199184
2019
Applications
Unspecified application
Species
Unspecified reactive species
Molecular omics 14:181-196 PubMed29770421
2018
Applications
Unspecified application
Species
Unspecified reactive species
Molecular medicine reports 13:2194-200 PubMed26782975
2016
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com